Phase I Study of the Humanized Antiepidermal Growth Factor Receptor Monoclonal Antibody EMD72000 in Patients With Advanced Solid Tumors That Express the Epidermal Growth Factor ReceptorU. Vanhoefer, José Baselga, J. Tillner et al.|Journal of Clinical Oncology|2003Cited by 259
New systemic frontline treatment for metastatic colorectal carcinomaAda Braun, P. Preusser, W. Achterrath et al.|Cancer|2004Cited by 71
The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecanAda Braun, U. Vanhoefer, S. Seeber et al.|Anti-Cancer Drugs|2005Cited by 30